NeoGenomics, Inc. Accounts Receivable, Allowance for Credit Loss
NeoGenomics, Inc. (NEO) had Accounts Receivable, Allowance for Credit Loss of $13.70 million as of 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2018-03-13
- 2017-12-31: Accounts Receivable, Allowance for Credit Loss $13.70M.
- 2017-09-30: Accounts Receivable, Allowance for Credit Loss $10.94M.
- 2017-06-30: Accounts Receivable, Allowance for Credit Loss $11.63M.
- 2017-03-31: Accounts Receivable, Allowance for Credit Loss $14.64M.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2017-12-31 | $13.70M 10-K · filed 2018-03-13 |
| 2017-09-30 | $10.94M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $11.63M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $14.64M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $13.70M 10-K · filed 2018-03-13 |
| 2015-12-31 | $4.76M 10-K · filed 2018-03-13 |
| 2014-12-31 | $4.18M 10-K · filed 2018-03-13 |
| 2013-12-31 | $4.54M 10-K · filed 2017-03-14 |
| 2012-12-31 | $3.00M 10-K · filed 2016-04-18 |
| 2011-12-31 | $2.15M 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |